Story perspectives

Rep. Lawler Slams Trump's Marijuana Reclassification Plan

12/16/2025

50 6

Summary

Story summary

Rep. Mike Lawler (R-N.Y.) criticized U.S. President Donald Trump’s consideration to reclassify marijuana as ill-advised.
He argued marijuana acts as a gateway drug, leading users to harder substances.
THC concentrations have risen from about 5% in the 1990s to 15–20% today.
He noted health risks from long-term use, including respiratory and mental health issues.
Despite 42 states and Washington, D.C., legalizing medical marijuana, Lawler remains opposed to reclassification.

1 of 1

Story summary

Rep. Mike Lawler (R-N.Y.) criticized U.S. President Donald Trump’s consideration to reclassify marijuana as ill-advised.
He argued marijuana acts as a gateway drug, leading users to harder substances.
THC concentrations have risen from about 5% in the 1990s to 15–20% today.
He noted health risks from long-term use, including respiratory and mental health issues.
Despite 42 states and Washington, D.C., legalizing medical marijuana, Lawler remains opposed to reclassification.